GLI Supports NIH Naming Dr. Marrazzo as New Director of the National Institute of Allergy and Infectious Diseases
Global Liver Institute supports the selection of Jeanne M. Marrazzo, M.D., as director of the National Institute of Allergy and Infectious Diseases (NIAID) by the acting director of the NIH. Dr. Marrazzo is currently the director of the Division of Infectious Diseases at the University of Alabama at Birmingham and is a Fellow of the American College of Physicians and of the Infectious Diseases Society of America. She follows Dr. Anthony Fauci as the appointee to lead the institute, which responds to outbreaks of infectious diseases and conducts basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.
As the recipient of the American Sexually Transmitted Diseases Association’s Distinguished Career Award, the highest recognition of contributions to research and mentoring in the field, Dr. Marrazzo will be able to translate her experience to broaden both the institute’s support of diverse trainees and its research focus on infectious diseases that impact the liver, such as viral hepatitis – a leading cause of liver cancer. Dr. Marrazzo is expected to begin her role as NIAID Director in the fall, and GLI looks forward to working closely with her in support of liver patients throughout the country.
About Global Liver Institute
Global Liver Institute (GLI) was built to solve the problems that matter to liver patients, equipping advocates to improve the lives of individuals and families impacted by liver disease. GLI promotes innovation, encourages collaboration, and supports the scaling of optimal approaches to help eradicate liver diseases. GLI believes liver health must take its place on the global public health agenda commensurate with the prevalence and impact of liver illness. GLI is the only patient-created, patient-driven nonprofit organization tackling liver health and all liver disease holistically, operating globally. Follow GLI on Facebook, Instagram, LinkedIn, and YouTube.